Peptides 2006 New Applications in Discovery, Manufacturing, and Therapeutics

To date, three types of molecules have been developed for the treatment of human diseases. These major classes of molecules are 1) small molecules, 2) antibodies, and 3) peptides. Currently, the majority of the therapeutic molecules developed and marketed are small molecules. However, with the recent development in several technologies in the areas of peptide synthesis, screening, stability, and modifications, peptides are now recognized as lead molecules for therapeutics.

This report contains a comprehensive analysis of peptide-based technologies, peptides for therapeutics, and their delivery mechanisms. In addition, it provides a thorough analysis of companies that have developed new peptides and related technologies.

Report Overview

> This report analyzes the current peptide market. In addition, it features an analysis of therapeutic peptide products in multiple disease indications, as well as an up to date overview of key patent issues in this space. > Numerous peptide therapeutic companies are profiled and details of their specialization, capabilities, and services are provided.

> The Report offers multiple experts' opinion on current application and issues related to peptides.

> Results from an analysis of a proprietary survey conducted on current issues in peptides are a key component of this report as well.

Learn about critical issues in this space such as:

> Advances made in peptides discovery

> Therapeutic potential of peptides in multiple diseases

> New peptides introduced to market

> Issues in peptides delivery

> Key players in peptide manufacturing, formulations and research

> Past and future growth in multiple peptide segments

> Challenges and obstacles in developing peptides

Questions Answered

> What are the current markets and future prospects for peptides?

> What are the major and minor steps required for the success of peptides in multiple disease conditions?

> Who are the current companies in peptide formulation, manufacturing and therapy?

> What is the current status of key peptide products?

> What peptides related issues are making the news?

By Anil Sehgal, Ph.D.

Dr. Anil Sehgal obtained his Ph.D. in Biomedical Sciences in 1994 from Old Dominion University and Eastern Virginia Medical School. He served as Assistant Member at the Pacific Northwest Cancer Foundation in Seattle before joining UCSF. He initiated a molecular marker program in the brain tumor area at UCSF. He has published over 20 publications and presented in numerous National and International Conferences. He also holds several patents in the area of markers and targets for cancer therapeutics. He currently works as an independent consultant for Bio-Pharma companies.

Published: June, 2006 Format PDF Pages 222
Table of Contents
Brochure

Price